High [qlco]
Incidence [qnco]
Carcinosarcoma [neop]
Patients [podg]
treated [topp]
Tamoxifen [orch, phsu]
Background [cnce]
Tamoxifen [orch, phsu]
ACT [topp]
Estrogen antagonist [phsu]
Breast tissue [bpoc]
Uterus [bpoc]
Tamoxifen [orch, phsu]
Agonist [phsu]
Estrogen Receptors [aapp, rcpt]
Hyperplasia [patf]
Neoplasia [neop]
Endometrium [bpoc]
objectives [inpr]
To [qlco]
Compare [acty]
Characteristics [qlco]
Patients [podg]
Uterine sarcoma [neop]
Not [ftcn]
treated [topp]
Tamoxifen [orch, phsu]
Methods [inpr]
Medical Records [inpr]
Women [popg]
Uterine sarcoma [neop]
treated [topp]
Medical center [hcro, mnob]
Israel [geoa]
reviewed [inpr]
disease characteristic [patf]
Histological type [clas]
Sarcoma [neop]
Demographics [idcn]
Treatments [topp]
Final [tmco]
Outcome [ftcn]
Compared [acty]
Patients [podg]
Not [ftcn]
Exposed [clna]
Tamoxifen [orch, phsu]
Result [ftcn]
Patients [podg]
Identified [qlco]
Exposed [clna]
Tamoxifen [orch, phsu]
One [qnco]
Mean [qnco]
Age [orga]
Exposed [clna]
Not [ftcn]
Exposed [clna]
Drug [phsu]
Rate [acty]
Uterine Carcinosarcoma [neop]
P NOS [aapp, imft]
Patients [podg]
Carcinosarcoma [neop]
Old [tmco]
Sarcoma [neop]
Patients [podg]
P NOS [aapp, imft]
statistically significant [qnco]
Two [qnco]
Group [idcn]
Rate [acty]
Diabetes Mellitus [dsyn]
Hypertension [dsyn]
Dyslipidaemia [dsyn]
Heart disease [dsyn]
Mean [qnco]
Time [tmco]
Diagnosis [fndg]
Death [orgf]
overall survival rate [qnco]
Carcinosarcoma [neop]
Patients [podg]
Not [ftcn]
Statistically [ocdi]
Different [qlco]
Sarcoma [neop]
Patients [podg]
Tamoxifen [orch, phsu]
Exposure NOS [inpo]
Not [ftcn]
Associated [qlco]
Overall [inpr]
Survival [acty]
Sarcoma [neop]
Patients [podg]
subgroup [virs]
Carcinosarcoma [neop]
Patients [podg]
Conclusions [idcn]
Tamoxifen [orch, phsu]
treatment [ftcn]
Associated [qlco]
Elevated [qlco]
Incidence [qnco]
Carcinosarcoma [neop]
Women [popg]
Uterine sarcoma [neop]
Not [ftcn]
Found [qnco]
To [qlco]
Associated [qlco]
Prognosis [hlca]
co-morbidity [idcn]
